Editorial
doi: 10.1016/S1359-6446(05)03707-4.
Can single-patient investigational new drug studies hurry slow trains to the fast track?
- PMID: 16580594
- DOI: 10.1016/S1359-6446(05)03707-4
Item in Clipboard
Editorial
Can single-patient investigational new drug studies hurry slow trains to the fast track?
Drug Discov Today.
2006 Mar.
Abstract
Tips from an Irish playwright and a Finnish oncologist could help the United States' National Cancer Institute reach its 2015 goal.
Similar articles
-
Slow start to phase 0 as researchers debate value.J Natl Cancer Inst. 2006 Jun 21;98(12):804-6. doi: 10.1093/jnci/djj249. J Natl Cancer Inst. 2006. PMID: 16788150 No abstract available.
-
Oncology's first Phase 0 trial.J Natl Cancer Inst. 2009 Jul 15;101(14):978-9. doi: 10.1093/jnci/djp213. Epub 2009 Jul 7. J Natl Cancer Inst. 2009. PMID: 19584322 No abstract available.
-
New office and new leader aim to streamline FDA cancer drug review process.J Natl Cancer Inst. 2005 May 18;97(10):708-9. doi: 10.1093/jnci/97.10.708. J Natl Cancer Inst. 2005. PMID: 15900036 No abstract available.
-
Phase 0 clinical trials in oncology: a paradigm shift for early drug development?Cancer Chemother Pharmacol. 2009 Mar;63(4):703-9. doi: 10.1007/s00280-008-0789-4. Epub 2008 Jul 10. Cancer Chemother Pharmacol. 2009. PMID: 18615251 Review.
-
Accelerated approval of oncology products: a decade of experience.J Natl Cancer Inst. 2004 Oct 20;96(20):1500-9. doi: 10.1093/jnci/djh279. J Natl Cancer Inst. 2004. PMID: 15494600 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
